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ABSTRACT
Circadian clocks have long been known to be
essential for the maintenance of physiological and
behavioral processes in a variety of organisms
ranging from plants to humans. Dysfunctions that
subvert gene expression of oscillatory circadian-
clock components may result in severe pathologies,
including tumors and metabolic disorders. While the
underlying molecular mechanisms and dynamics of
complex gene behavior are not fully understood,
synthetic approaches have provided substantial
insight into the operation of complex control
circuits, including that of oscillatory networks.
Using iterative cycles of mathematical model-
guided design and experimental analyses, we have
developed a novel low-frequency mammalian
oscillator. It incorporates intronically encoded
siRNA-based silencing of the tetracycline-
dependent transactivator to enable the autonomous
and robust expression of a fluorescent transgene
with periods of 26h, a circadian clock-like oscilla-
tory behavior. Using fluorescence-based time-lapse
microscopy of engineered CHO-K1 cells, we profiled
expression dynamics of a destabilized yellow fluo-
rescent protein variant in single cells and real time.
The novel oscillator design may enable further
insights into the system dynamics of natural
periodic processes as well as into siRNA-mediated
transcription silencing. It may foster advances
in design, analysis and application of complex syn-
thetic systems in future gene therapy initiatives.
INTRODUCTION
The rapidly developing ﬁeld of synthetic biology has
emerged as a discipline capable of linking theoretical
model predictions to experimental implementations con-
sisting of minimal modular building blocks arranged to
form synthetic networks (1) with diﬀerent levels of com-
plexity (2–9). Substantial information on such minimal
units and circuitry originated from prokaryotes (10–18)
and the relatively recent development of heterologous
mammalian gene regulation technologies (19–21) enabled
subsequent applications in complex mammalian systems
(2,3,22,23).
In synthetic biology, oscillatory behavior has gained
substantial attention due to its impact on repair (24),
metabolic (25) and signaling pathways (26–27). Such
pathways, like the p53-mdm2-triggered apoptosis cascade
(28), NF-kB-regulated immune responses (29) or Hes1-
mediated developmental control (30), are based on
periodic induction of negative feedback loops controlling
expression of key pathway factors (31,32).
Utilizing antisense-mediated silencing of a transacti-
vator, we have recently created a synthetic gene network
capable of oscillatory expression of the green ﬂuorescent
protein (22). Future applications, however, are expected
to require ﬁne-tuning of oscillatory properties, such as
frequency and amplitude. This could be achieved by alter-
native selection and reconﬁguration of the underlying
modular building blocks. Here, we present an alternative
oscillatory network that displays robust low-frequency
ﬂuctuations in target gene expression. Capitalizing on
recent progress showing that RNA interference may be a
powerful component of synthetic gene networks (33,34),
we have designed a synthetic mammalian clock that
combines siRNA-mediated, time-delayed negative
feedback loop with autoregulated expression of the
tetracycline-dependent transactivator (tTA). The experi-
mental data thus obtained were in good agreement
with a mathematical model based on ordinary diﬀer-
ential equations. Information gained from such
combined dynamic studies should facilitate advances in
our understanding of natural circadian clocks and
rhythms (35).
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Expression vector design
pBP283 (PETR3!d2EYFP), harboring a destabilized
enhanced yellow ﬂuorescent protein (d2EYFP) under
control of the erythromycin-responsive promoter
(PETR3), was constructed by excising d2EYFP from
pd2EYFP (Clontech) using EcoRI/NotI and cloning it
into the corresponding sites (EcoRI/NotI) of pBP90
(36). pDG156 (PhCMV* 1-ET1), containing the
erythromycin-dependent transactivator [ET1, E-VP16;
(37)] driven by the tetracycline-responsive promoter
(PhCMV* 1) was designed by excising PhCMV* 1 from
pMF111 (38) by SspI/EcoRI and cloning it into the cor-
responding sites (SspI/EcoRI) of pWW35 (19). pDG157
(PhCMV* 1!E-siRNALUC-VP16) expresses the ET1,
E-VP16; (37) containing an intronically encoded siRNA
speciﬁc for ﬁreﬂy luciferase mRNAs (siRNALUC;n t
62–80). pDG157 was obtained by replacing PSV40 of
pDG17 (39) with PhCMV* 1 (40) via SspI/EcoRI.
pDG178 (PhCMV* 1!tTA) harboring an autoregulated
expression unit for tetracycline-responsive control of the
tTA was obtained by excising tTA from pSAM200 (38)
using EcoRI/BssHII into pDG156, thereby replacing ET1.
pND10 (PhCMV* 1!TAGLUC-tTA) contains an expres-
sion unit for PhCMV* 1-driven expression of the tTA
preceded by a noncoding sequence tag derived from the
ﬁreﬂy luciferase coding sequence (nt 62–80). pND10 was
constructed in two steps, ﬁrst by replacing PhCMV* 1 of
pDG178 with PhEF1 -TAGLUC (PhEF1a, human elongation
factor 1a promoter) of pDG54 via SspI/EcoRI and then
by replacing PhEF1a with PhCMV* 1 of pDG178 via SspI/
KpnI.
Cell culture, transfection and gene regulation
Chinese hamster ovary cells (CHO-K1, ATCC CCL61)
were cultivated in ChoMaster HTS (Cell Culture
Technologies, Gravesano, Switzerland) supplemented
with 5% fetal calf serum (Pan Biotech GmbH,
Aidenbach, Germany; cat. no. 3302-P231902, lot no.
P231902). CHO-K1 were cultivated at 37 Ci na
humidiﬁed atmosphere containing 5% CO2, and 35000
cells were transfected using the FuGENE6 transfection
reagent (Roche Molecular Biochemicals, lot. no.
93535720) and a network-encoding plasmid mixture
calibrated to a total of 1.2mg DNA using the extender
vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA).
Transfection experiments were standardized to provide
eﬃciencies of up to 35±5%. The number of oscillating
cells was indicated as percent relative to the total number
of transfected cells (100%). Transfected cells were arrested
in the G1 phase by a down-shift of the cultivation temper-
ature to 32 C (41), and monitoring of the ﬂuorescence
dynamics by time-lapse microscopy was started 18h
posttransfection (t=0).
Fluorescence imaging
Time-lapse ﬂuorescence microscopy was performed using
an inverted Leica ﬂuorescence microscope (Leica
Microsystems DMI 6000B, 11888107) equipped with an
incubation chamber, a Leica DFC350FX R2 digital
camera (Leica, cat. no: 112730043), an 10  objective
(Leica, Obj. HC PL FL 10 /0.30 PH1 -/D 11.0, cat. no.
11506507) and the following excitation/emission ﬁlter
set: d2EYFP (513/527nm; C/Y/R, cat. no. 11513897).
Time-lapse movies were produced with the LAS AF
imaging software (Leica FW4000-TZ, cat. no. 12723979)
set to exposure times of 610ms every 20min. Fluorescence
was quantiﬁed for single cells using a custom-designed
software implemented in MATLAB (Mathworks,
Nantucket/MA, USA) All details on software develop-
ment are available as Supplementary Data.
Computational modeling
All details on mathematical models and computational
methods are provided as Supplementary Data. Simula-
tions were performed with MATLAB, Version R2007b.
RESULTS
Design of the low-frequency mammalian oscillator
The low-frequency mammalian oscillator (Figure 1a)
consists of: (i) an autoregulated expression unit harboring
the tTA and an untranslated Photinus pyralis ﬁreﬂy
luciferase-derived sequence tag (TAGLUC; 42, 43)
targeted by a luciferase-speciﬁc siRNA (siRNALUC; 42)
under control of the tTA-speciﬁc tetracycline-responsive
promoter (PhCMV* 1;P hCMV* 1!TAGLUC-tTA); (ii)
aP hCMV* 1-driven erythromycin-dependent transac-
tivator [ET1; E-VP16; (37)] harboring an intronic
siRNALUC speciﬁc for LUC-tagged tTA (TAGLUC-tTA)
between the macrolide-dependent repressor (E) and the
Herpes simplex-derived transactivation domain (VP16)
(PhCMV* 1!E-siRNALUC-VP16); and (iii) a destabilized
yellow ﬂuorescent protein variant with a half-life of 2h
(d2EYFP) (44, 45) controlled by the ET1-speciﬁc
macrolide-responsive promoter (PETR3;P ETR3-d2EYFP)
(Figure 1a).
When co-transfected into mammalian cells, leaky
PhCMV* 1-mediatedTAGLUC-tTAtranscriptionisexpected
to initiate an autoregulated positive feedback loop sus-
taining high-level expression of tTA and consequently
of PhCMV* 1-driven E-siRNALUC-VP16 expression.
Constitutive splicing of E-siRNALUC-VP16 produces
equimolar amounts of ET1 (E-VP16) and siRNALUC,
which results in concomitantly increasing ET1-triggered
PETR3-driven d2EYFP expression and siRNALUC-
mediated breakdown of LUC-tagged tTA transcripts.
siRNALUC-based depletion of TAGLUC-tTA transcripts
will reduce tTA levels and temporarily shut down the
network. This results in low d2EYFP expression and low
siRNALUC production, which eventually allows the circuit
to start over again. The gene network can be tuned by the
addition of tetracycline and erythromycin to regulate
PhCMV* 1 and PETR3 promoter activity, respectively.
Model-based analysis of circuit behavior
To evaluate the general capability of the network to gen-
erate oscillatory behavior, we developed a mathematical
Nucleic Acids Research,2010, Vol.38, No. 8 2703model based on ordinary diﬀerential equations (see
Figure 1b and Supplementary Data). This deterministic
model describes the circuitry behavior in a mechanistic
fashion. A ﬁrst model prediction based on experimentally
determined, as well as literature-based, parameter sets (see
Supplementary Data) demonstrated the general capacity
of the circuit to display oscillatory gene expression with
periods similar to those observed for natural circadian
clocks (Figure 1c and d).
Evaluation of circuit behavior in CHO-K1 cells by
monitoring d2EYFP expression
According to model simulations, any inactivation of
transactivators tTA and/or ET1 by the addition of antibi-
otics would disrupt the rhythmic expression pattern
(Supplementary Figure 1). The impact of regulating anti-
biotics on the system was therefore ﬁrst analyzed
to validate the functionality of the single components.
For this purpose, pND10 (PhCMV* 1!TAGLUC-tTA),
pDG157 (PhCMV* 1!E-siRNALUC-VP16) and pBP283
(PETR3!d2EYFP) were co-transfected at equimolar
ratios (1:1:1), followed by subsequent addition of
(i) 200ng/500ml tetracycline (Figure 2a) or (ii) 200ng/
500ml erythromycin (Figure 2b). As expected, addition
of either antibiotic disrupted the oscillatory behavior, lead-
ing to decreasing levels of d2EYFP ﬂuorescence overtime.
In contrast, model predictions suggested that the sys-
tem would be insensitive to variations in the amount
of transfected single components (Figure 3 and
Supplementary Data). Therefore, we next evaluated the
eﬀect of plasmid dosage variations by co-transfecting
pND10 (PhCMV* 1!TAGLUC-tTA), pDG157 (PETR3!
E-siRNALUC-VP16) and pBP283 (PETR3!d2EYFP) at
diﬀering amounts, namely 1:1:1 (100ng each, Figure 4a),
0.5:0.5:1 (Figure 4b), 2:2:1 (Figure 4c), and varying ratios
2:1:1 (Figure 5a) and 1:2:1 (Figure 5b). All variations dis-
played oscillatory behavior with similar periods of  26h
and with substantial amplitudes. Hence, the experimental
data conﬁrmed the theoretically predicted robustness of
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Figure 1. Mammalian clock components and predicted oscillation dynamics. (a) The mammalian oscillator consists of an autoregulated expression
unit encoding the tTA under control of the tetracycline-responsive promoter (PhCMV* 1). A luciferase-speciﬁc sequence TAG engineered into the
noncoding 50-region of the tTA transcript enables interference-based silencing of TAGLUC-tTA mRNAs using a luciferase-speciﬁc siRNA
(siRNALUC). siRNALUC is intronically encoded within the macrolide-dependent transactivator (ET1; between the macrolide-responsive repressor
(E) and the Herpes simplex-derived transactivation domain VP16; E-siRNALUC-VP16), which is driven by the tTA-speciﬁc PhCMV* 1. Splicing of
E-siRNALUC-VP16 transcripts produces both, siRNALUC, which triggers interference-based elimination of TAGLUC-tTA mRNAs and ET1, which
transactivates PETR3, thereby controlling expression of the destabilized d2EYFP and enabling visualization of the oscillatory network dynamics.
Tetracycline and erythromycin can be used to modulate tTA- and ET1-mediated induction of PhCMV* 1 and PETR3, respectively. (b) Intracellular
processes considered in the mathematical model. Transcription (green arrow), translation and protein folding (blue arrow), degradation (orange
arrow) and RNA interference (red arrow). (c and d) Model predictions for the reference parameter set (all plasmids transfected at a 1:1:1 ratio,
no antibiotics) (c) with protein concentrations (tTA, solid line; ET1, dashed line; active ﬂuorescent d2EYFP, dotted line) and (d) with mRNA
concentrations (tTA, solid line; ET1, dashed line), and RISC/siRNALUC complex (dotted line).
2704 Nucleic Acids Research, 2010,Vol.38, No. 8the network to moderate changes in the amounts of single
components. This contrasts with the observed and pre-
dicted sensitivity of the oscillatory behavior to plasmid
dosage in our earlier synthetic oscillator based on
antisense-mediated silencing of the tTA (22). There,
changes in ratio and/or amount of system components
inﬂuence the period and amplitude of oscillatory gene
expression signiﬁcantly.
When expressing excessive amounts of either pND10
(PhCMV* 1!TAGLUC-tTA) or pDG157 (PETR3!
E-siRNALUC-VP16) using ratios of 10:1:1 (Figure 5c)
and 1:10:1 (Figure 5d), the oscillatory circuit was substan-
tially repressed. Interestingly, even with a 10-fold excess in
tTA gene dosage, silencing induced visible ﬂuctuations in
reporter gene expression (Figure 5c). In contrast, a 10-fold
excess of siRNALUC, which removes TAGLUC-tTA tran-
scripts from the system, completely eliminated such
behavior (Figure 5d). These results point to a major role
of the amplifying and long-lasting siRNA-mediated
silencing mechanism in generating the observed network
behavior.
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Figure 2. Impact of regulating antibiotics on the mammalian oscillator components and systems behavior using single cell time-lapse ﬂuorescence
microscopy of transfected CHO-K1. (a) CHO-K1 co-transfected with pND10 (PhCMV* 1!TAGLUC-tTA), pDG157 (PhCMV* 1!E-siRNALUC-VP16)
and pBP283 (PETR3!d2EYFP); 200ng tetracycline was added to the culture, (b) CHO-K1 transfected with pND10, pDG157 and pBP283; 200ng
erythromycin was added to the culture. Left panels show ﬂuorescence dynamics and micrographs of a representative individual cell, and right panels
show the ﬂuorescence proﬁles of several cells with t=0 corresponding to the onset of ﬂuorescence.
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Alignment of mathematically simulated and predicted period (gray
disc) with the experimental data (black diamonds with error bars) for
the conditions (i) pND10 (PhCMV* 1!TAGLUC-tTA):pDG157
(PhCMV* 1!E-siRNALUC-VP16):pBP283 (PETR3!d2EYFP); 50ng:
50ng:100ng, (ii) 100ng:100ng:100ng, (iii) 200ng:200ng:100ng.
Nucleic Acids Research,2010, Vol.38, No. 8 2705To further characterize the impact of siRNALUC
activity and speciﬁcity, we co-transfected CHO-K1 cells
with (i) pDG178 (PhCMV* 1!tTA) lacking the
50-TAGLUC, together with pDG157 (PhCMV* 1!
E-siRNALUC-VP16) and pBP283 (PETR3!d2EYFP) and
(ii) pND10 (PhCMV*-1!TAGLUC-tTA), pDG156
(PETR3!E-VP16) lacking the intronically encoded
siRNALUC and pBP283 (PETR3!d2EYFP) (Figure 6a
and b). For both conditions, we detected no oscillations
but a constitutive increase in ﬂuorescent intensity
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Figure 4. Characterization of oscillator dynamics using single-cell time-lapse ﬂuorescence microscopy of CHO-K1 transfected with diﬀerent amounts
of oscillator components. (a–c) CHO-K1 co-transfected with pND10 (PhCMV* 1!TAGLUC-tTA), pDG157 (PhCMV* 1!E-siRNALUC-VP16) and
pBP283 (PETR3!d2EYFP): (a) plasmid ratio of 1:1:1, no antibiotics; (b) 0.5:0.5:1, no antibiotics; and (c) 2:2:1, no antibiotics. Left panels show
ﬂuorescence dynamics and micrographs of a representative individual cell, and right panels show the ﬂuorescence proﬁles of several cells with t=0
corresponding to the onset of ﬂuorescence.
2706 Nucleic Acids Research, 2010,Vol.38, No. 80 10 20 30 40 50 60 70
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
time (hours)
0 1 02 03 04 05 06 07 0
time (hours)
0 1 02 03 04 05 06 07 0
time (hours)
0 1 02 03 04 05 06 07 0
time (hours)
01 0 2 0 3 0 4 0 5 0 6 0 7 0
time (hours)
01 0 2 0 3 0 4 0 5 0 6 0 7 0
time (hours)
0 1 02 03 04 05 06 07 0
time (hours)
0 1 02 03 04 05 06 07 0
time (hours)
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
)
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
F
l
u
o
r
e
s
c
e
n
c
e
 
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
 
x
 
1
0
4
) (a)
(b)
(c)
(d)
Figure 5. Characterization of oscillator dynamics using single-cell time-lapse ﬂuorescence microscopy of CHO-K1 transfected with diﬀerent ratios of
oscillator components. (a–d) Single-cell time-lapse ﬂuorescence microscopy of CHO-K1 co-transfected with pND10 (PhCMV* 1!TAGLUC-tTA),
pDG157 (PhCMV* 1!E-siRNALUC-VP16) and pBP283 (PETR3!d2EYFP): (a) plasmid ratio of 2:1:1, no antibiotics; (b) 1:2:1, no antibiotics;
(c) 10:1:1, no antibiotics; and (d) 1:10:1, no antibiotics. Left panels show ﬂuorescence dynamics and micrographs of a representative individual
cell, and right panels show the ﬂuorescence proﬁles of several cells with t=0 corresponding to the onset of ﬂuorescence.
Nucleic Acids Research,2010, Vol.38, No. 8 2707over time. This was comparable with conditions in
which only pDG157 (PhCMV* 1!E-siRNALUC-VP16)
and pBP283 (PETR3!d2EYFP) were co-transfected
(Figure 6c). The observed oscillatory behavior is therefore
speciﬁc and directly linked to the siRNALUC-mediated
elimination of TAGLUC-tTA transcripts that leads to
silencing of tTA expression. These observations conﬁrm
functional siRNA-mediated breakdown of target mRNAs
and corroborate modeling results based on a speciﬁc set of
known RNA-interference parameters (see Supplementary
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Figure 6. Evaluation of siRNA speciﬁcity on the oscillatory behavior using single-cell time-lapse ﬂuorescence microscopy of transfected CHO-K1.
(a) CHO-K1 co-transfected with pDG178 (PhCMV* 1!tTA), pDG157 (PhCMV* 1!E-siRNALUC-VP16) and pBP283 (PETR3!d2EYFP) at a plasmid
ratio of 1:1:1, no antibiotics, (b) co-transfection of pND10 (PhCMV* 1!TAGLUC-tTA), pDG156 (PhCMV* 1!ET1; ET1, E-VP16) and pBP283
(PETR3!d2EYFP) at a plasmid ratio of 1:1:1, no antibiotics and (c) co-transfection of pDG157 (PhCMV* 1!E-siRNALUC-VP16) and pBP283
(PETR3!d2EYFP) at a plasmid ratio of 1:1, no antibiotics. Left panels show ﬂuorescence dynamics and micrographs of a representative individual
cell and right panels show the ﬂuorescence proﬁles of several cells with t=0 corresponding to the onset of ﬂuorescence.
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destruction capacity by RNA interference components
such as RISC and DICER (46), even residual siRNA
levels were predicted to completely eliminate leaky tTA
transcripts and, therefore, prevent tTA production
(Figure 5c and d).
Quantitative analysis of network behavior using
automated image tracking and quantiﬁcation
To obtain statistically relevant information on the
network dynamics, the experimental data were systemati-
cally analyzed using customized tracking and image
analysis software. Using high-throughput processing of
acquired image series (for detailed information see
Supplementary Data), we determined a consistent period
for all analyzed plasmid ratio variations. In addition, we
obtained signiﬁcant relative amplitudes of >30% for total
cellular ﬂuorescence (Table 1).
With respect to the eﬃciency of oscillator behavior in
the cell population, we found the highest number of cells
that showed oscillating d2EYFP ﬂuorescence for
transfection with equimolar plasmid ratios (1:1:1). A
movie showing the oscillatory behavior of the system
after transfection of pND10 (PhCMV* 1!TAGLUC-tTA),
pDG157 (PETR3!E-siRNALUC-VP16) and pBP283
(PETR3!d2EYFP) at equimolar ratios 1:1:1 (100ng
each) can be found at http://mf-229-serv.ethz.ch/fussi_
download/marcel/suppmov.mov. The share of oscillating
cells was 11.7% compared to 9.7% (2:1:1), 8.2% (1:2:1),
7.1% (2:2:1) and 17.6% (0.5:0.5:1) (Table 1). In contrast
to the ﬁrst-generation mammalian oscillator (22), which
was tunable by varying plasmid ratio and amount (i.e.
it exhibited frequency and amplitude changes in
response to variations in these parameters), the alternative
low-frequency mammalian oscillator is largely insensitive
to component ﬂuctuations.
DISCUSSION
The design of functional replicas of natural circadian
clocks using native circadian clock components has been
unsuccessful, suggesting that engineering of oscillatory
behavior remains a non-trivial challenge (47). Synthetic
biology at this point seems to be a valuable alternative,
as several synthetic networks in prokaryotic backgrounds
have eﬃciently produced functional circuits displaying
damped (48), self-sustained (11), tunable (49,50) or
metabolically (51) controlled oscillations. By incorporat-
ing posttranscriptional antisense-based control mecha-
nisms, together with transcriptional regulation, we have
previously created self-sustained and tunable oscillatory
behavior in mammalian cells (22). However, the under-
standing and availability of single building blocks for
complex network reconstruction is still relatively low.
Any successful future initiative for gene therapeutic appli-
cations will require a broad spectrum of single compo-
nents that can be interconnected to generate tunable
and predictable oscillatory behavior in terms of frequency
and amplitude of target gene expression levels. Our
intronic-siRNA-based low frequency and robust oscillator
therefore not only provides another tool for oscillatory
gene expression. Due to its characteristics (siRNA-based
feedback loops, long period, robustness to variations of
DNA amounts and ratios), it serves as a valuable addition
as well as counterpart to established systems. Besides syn-
chronization of oscillators across a population of cells
which was recently achieved in bacteria (17,18), the
design of synthetic clocks with increased robustness of
oscillatory behavior to variations in relative expression
Table 1. Overview on oscillation characteristics resulting from diﬀerent conditions
Transfected plasmid Amount (ng) Antibiotic No. of cells
analyzed
Oscillating
cells (%)
Period (h) Relative
amplitude (%)
Figure
pND10:pDG157:pBP283 100:100:100 Tetracycline 109 0 (0.0)    2a
pND10:pDG157:pBP283 100:100:100 Erythromycin 23 0 (0.0)    2b
pND10:pDG157:pBP283 100:100:100 None 336 39 (11.6) 25.8±7.6 34.8±22.5 4a
pND10:pDG157:pBP283 50:50:100 None 34 6 (17.6) 23.1±11.5 28.3±17.5 4b
pND10:pDG157:pBP283 200:200:100 None 588 42 (7.1) 26.7±7.0 41.7±21.4 4c
pND10:pDG157:pBP283 200:100:100 None 318 31 (9.7) 26.0±8.5 29.7±16.6 5a
pND10:pDG157:pBP283 100:200:100 None 425 35 (8.2) 25.3±7.5 33.1±19.1 5b
pND10:pDG157:pBP283 1000:100:100 None 192 9 (4.7) 26.7±10.5 33.3±19.7 5c
pND10:pDG157:pBP283 100:1000:100 None 282 0 (0.0) - - 5d
pDG178:pDG157:pBP283
(no TAGLUC)
100:100:100 None 93 0 (0.0) - - 6a
pND010:pDG156:pBP283
(no siRNALUC)
100:100:100 None 152 0 (0.0) - - 6b
pDG157:pBP283 (no tTA) 100:100 None 50 0 (0.0) - - 6c
ET1, macrolide-dependent transactivator (E-VP16); pBP283 (PETR3-d2EYFP), expression vector encoding a d2EYFP under control of the
erythromycin-responsive promoter; PETR3, macrolide-responsive promoter (ETR-PhCMVmin); PhCMV, promoter of the human cytomegalovirus imme-
diate early promoter; PhCMVmin: minimal version of PhCMV;P hCMV* 1, tetracycline-responsive promoter (tetO7-PhCMVmin); pDG156 (PhCMV* 1-ET1),
expression vector encoding the erythromycin-dependent transactivator (ET1, E-VP16); pDG157 (PhCMV* 1-E-siRNALUC-VP16), expression vector
encoding ET1 containing an intronically encoded siRNA speciﬁc for ﬁreﬂy luciferase mRNA (siRNALUC; nt 62–80); pDG178 (PhCMV* 1-tTA),
autoregulated tTA expression vector; pND10 (PhCMV* 1-TAGLUC-tTA), tTA expression vector containing an siRNALUC-speciﬁc tag (TAGLUC)i n
the 50 untranslated region derived from the ﬁreﬂy luciferase (nt 62–80); siRNALUC, ﬁreﬂy luciferase-speciﬁc siRNA; TAGLUC, ﬁreﬂy
luciferase-speciﬁc sequence tag; tTA, tetracycline-dependent transactivator (TetR-VP16); VP16, transactivation domain of Herpes simplex virus.
Nucleic Acids Research,2010, Vol.38, No. 8 2709of network components and intrinsic noise remain major
challenges on the way to use rhythmic transgene expres-
sion dosing in future therapeutic applications. Based on
extensive simulations of novel oscillator architectures
using a mathematical model, we have chosen to combine
a two-level transcription cascade (autoregulated tTA
expression triggers expression of the ET1 transactivator
which induces d2EYFP expression) with an intronic
siRNA-based negative feedback loop eliminating
tTA-encoding transcripts by RNA interference. This
network design enabled oscillating d2EYFP expression
with a ﬁxed frequency and amplitude that was almost
insensitive to changes in plasmid ratio and dosage. Such
extensions will make custom-tailored designs of regulatory
feedback loops for speciﬁc applications possible.
Furthermore, new insights into intronic siRNA-mediated
silencing impact and dynamics may advance the under-
standing of naturally occurring silencing-mediated feed-
back and feed-forward circuits.
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